Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group-Reference-Cited by-同舟云学术

Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group

Published:2010-04-29 Issue:9 Volume:37 Page:1633-1642
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Bodet-Milin Caroline,Touzeau Cyrille,Leux Christophe,Sahin Mehmet,Moreau Anne,Maisonneuve Hervé,Morineau Nadine,Jardel Henry,Moreau Philippe,Gallazini-Crépin Céline,Gries Pascal,Gressin Rémy,Harousseau Jean-Luc,Mohty Mohamad,Moreau Philippe,Kraeber-Bodere Françoise,Le Gouill Steven

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-010-1469-2.pdf

Reference27 articles.

1. Zhou Y, Wang H, Fang W, Romaguer JE, Zhang Y, Delasalle KB, et al. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer 2008;113:791–8.

2. Herrmann A, Hoster E, Zwingers T, Brittinger G, Engelhard M, Meusers P, et al. Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol 2009;27:511–8.

3. Bernard M, Gressin R, Lefrère F, Drénou B, Branger B, Caulet-Maugendre S, et al. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia 2001;15:1785–91.

4. Determann O, Hoster E, Ott G, Wolfram BH, Loddenkemper C, Hansmann ML, et al. Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood 2008;111:2385–7.

5. Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 2005;131:29–38.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ПЭТ-КТ при гематологических злокачественных опухолях: что достигнуто и к чему стремиться;Clinical Oncohematology;2024-04-01

2. PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies;Cancers;2022-11-30

3. [¹⁸F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma;Leukemia & Lymphoma;2022-10-12

4. The diagnosis and management of suspected lymphoma in general practice;European Journal of Haematology;2022-09-25

5. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1—Clinical);Journal of Nuclear Medicine;2022-07-14